Influence of a Latrophilin 3 (LPHN3) risk haplotype on event-related potential measures of cognitive response control in attention-deficit hyperactivity disorder (ADHD)

European Neuropsychopharmacology

Volumn 23, Issue 6, 2013, Pages 458-468

  Fallgatter, Andreas J ^a,b   Ehlis, Ann Christine ^a,b   Dresler, Thomas ^a,b   Reif, Andreas ^b   Jacob, Christian P ^b   Arcos Burgos, Mauricio ^c   Muenke, Maximilian ^c   Lesch, Klaus Peter ^b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^c Biology and Environment   (Australia)

Author keywords

Attention deficit hyperactivity disorder (ADHD); Go NoGo; Imaging genetics; Latrophilin 3 (LPHN3); Prefrontal cortex

Indexed keywords

LATROPHILIN 3; PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; COGNITION; CONTINUOUS PERFORMANCE TEST; ELECTROENCEPHALOGRAPHY; EVENT RELATED POTENTIAL; FEMALE; FUNCTION TEST; GENETIC RISK; HAPLOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BEHAVIOR; BIOLOGICAL MARKERS; COGNITION DISORDERS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; ELECTROENCEPHALOGRAPHY; EVOKED POTENTIALS; FEMALE; GENETIC ASSOCIATION STUDIES; GERMANY; HUMANS; MALE; NERVE TISSUE PROTEINS; NEURONS; POLYMORPHISM, SINGLE NUCLEOTIDE; PREFRONTAL CORTEX; PSYCHOMOTOR PERFORMANCE; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, PEPTIDE; YOUNG ADULT;

EID: 84877922729     PISSN: 0924977X     EISSN: 18737862     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2012.11.001     Document Type: Article

References (79)

1. Almasy L., Blangero J. Endophenotypes as quantitative risk factors for psychiatric disease: rationale and study design. Am. J. Med. Genet. 2001, 105:42-44.
2. Arcos-Burgos M., Castellanos F.X., Pineda D., Lopera F., Palacio J.D., Palacio L.G., Rapoport J.L., Berg K., Bailey-Wilson J.E., Muenke M. Attention-deficit/hyperactivity disorder in a population isolate: linkage to loci at 4q13.2, 5q33.3, 11q22, and 17p11. Am. J. Hum. Genet. 2004, 75:998-1014.
3. Arcos-Burgos M., Jain M., Acosta M.T., Shively S., Stanescu H., Wallis D., Domene S., Velez J.I., Karkera J.D., Balog J., Berg K., Kleta R., Gahl W.A., Roessler E., Long R., Lie J., Pineda D., Londono A.C., Palacio J.D., Arbelaez A., Lopera F., Elia J., Hakonarson H., Johansson S., Knappskog P.M., Haavik J., Ribases M., Cormand B., Bayes M., Casas M., Ramos-Quiroga J.A., Hervas A., Maher B.S., Faraone S.V., Seitz C., Freitag C.M., Palmason H., Meyer J., Romanos M., Walitza S., Hemminger U., Warnke A., Romanos J., Renner T., Jacob C., Lesch K.P., Swanson J., Vortmeyer A., Bailey-Wilson J.E., Castellanos F.X., Muenke M. A common variant of the latrophilin 3 gene, LPHN3, confers susceptibility to ADHD and predicts effectiveness of stimulant medication. Mol. Psychiatry 2010, 15:1053-1066.
4. Baehne C.G., Ehlis A.C., Plichta M.M., Conzelmann A., Pauli P., Jacob C., Gutknecht L., Lesch K.P., Fallgatter A.J. Tph2 gene variants modulate response control processes in adult ADHD patients and healthy individuals. Mol. Psychiatry 2009, 14:1032-1039.
5. Barkley R. Attention-deficit hyperactivity disorder: A Handbook for Diagnosis and Treatment 1998, Guilford, New York. 2nd edition.
6. Barkley R.A. Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD. Psychol. Bull. 1997, 121:65-94.
7. Barkley R.A., Grodzinsky G., DuPaul G.J. Frontal lobe functions in attention deficit disorder with and without hyperactivity: a review and research report. J. Abnorm. Child Psychol. 1992, 20:163-188.
8. Becker T., Knapp M. Maximum-likelihood estimation of haplotype frequencies in nuclear families. Genet. Epidemiol. 2004, 27:21-32.
9. Berridge C.W., Devilbiss D.M., Andrzejewski M.E., Arnsten A.F., Kelley A.E., Schmeichel B., Hamilton C., Spencer R.C. Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function. Biol. Psychiatry 2006, 60:1111-1120.
10. Biederman J. Attention-deficit/hyperactivity disorder: a selective overview. Biol. Psychiatry 2005, 57:1215-1220.
11. Birnbaum H.G., Kessler R.C., Lowe S.W., Secnik K., Greenberg P.E., Leong S.A., Swensen A.R. Costs of attention deficit-hyperactivity disorder (ADHD) in the US: excess costs of persons with ADHD and their family members in 2000. Curr. Med. Res. Opin. 2005, 21:195-206.
12. Bookheimer S.Y., Strojwas M.H., Cohen M.S., Saunders A.M., Pericak-Vance M.A., Mazziotta J.C., Small G.W. Patterns of brain activation in people at risk for Alzheimer's disease. N. Engl. J. Med. 2000, 343:450-456.
13. Borger N., van der Meere J. Motor control and state regulation in children with ADHD: a cardiac response study. Biol. Psychol 2000, 51:247-267.
14. Bush G., Frazier J.A., Rauch S.L., Seidman L.J., Whalen P.J., Jenike M.A., Rosen B.R., Biederman J. Anterior cingulate cortex dysfunction in attention-deficit/hyperactivity disorder revealed by fMRI and the counting stroop. Biol. Psychiatry 1999, 45:1542-1552.
15. Dhar M., Been P.H., Minderaa R.B., Althaus M. Information processing differences and similarities in adults with dyslexia and adults with attention deficit hyperactivity disorder during a continuous performance test: a study of cortical potentials. Neuropsychologia 2010, 48(10):3045-3056.
16. Doehnert, M., Brandeis, D., Schneider, G., Drechsler, R., Steinhausen, H.C. A neurophysiological marker of impaired preparation in an 11-year follow-up study of attention-deficit/hyperactivity disorder (ADHD). J. Child Psychol. Psychiatry , in press. http://10.1111/j.1469-7610.2012.02572.x.
17. Domene S., Stanescu H., Wallis D., Tinloy B., Pineda D.E., Kleta R., Arcos-Burgos M., Roessler E., Muenke M. Screening of human LPHN3 for variants with a potential impact on ADHD susceptibility. Am. J. Med. Genet. B 2011, 156B:11-18.
18. Döpfner M., Lehmkuhl G. Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung - Neuropsychologie. Neurobiologie psychischer Störungen 2006, 671-689. Springer Medizin Verlag, Heidelberg. H. Förstl, M. Hautzinger, G. Roth (Eds.).
19. Dresler T., Ehlis A.C., Heinzel S., Renner T.J., Reif A., Baehne C.G., Heine M., Boreatti-Hummer A., Jacob C.P., Lesch K.P., Fallgatter A.J. Dopamine transporter (SLC6A3) genotype impacts neurophysiological correlates of cognitive response control in an adult sample of patients with ADHD. Neuropsychopharmacology 2010, 35:2193-2202.
20. Egan M.F., Goldberg T.E., Kolachana B.S., Callicott J.H., Mazzanti C.M., Straub R.E., Goldman D., Weinberger D.R. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc. Natl. Acad. Sci. USA 2001, 98:6917-6922.
21. Ehlis A.C., Reif A., Herrmann M.J., Lesch K.P., Fallgatter A.J. Impact of catechol-O-methyltransferase on prefrontal brain functioning in schizophrenia spectrum disorders. Neuropsychopharmacology 2007, 32:162-170.
22. Eimer M. Effects of attention and stimulus probability on ERPs in a Go/Nogo task. Biol. Psychol. 1993, 35:123-138.
23. Fallgatter A.J., Aranda D.R., Bartsch A.J., Herrmann M.J. Long-term reliability of electrophysiologic response control parameters. J Clin. Neurophysiol. 2002, 19:61-66.
24. Fallgatter A.J., Bartsch A.J., Herrmann M.J. Electrophysiological measurements of anterior cingulate function. J. Neural Transm. 2002, 109:977-988.
25. Fallgatter A.J., Bartsch A.J., Strik W.K., Mueller T.J., Eisenack S.S., Neuhauser B., Aranda D., Herrmann M.J. Test-retest reliability of electrophysiological parameters related to cognitive motor control. Clin. Neurophysiol. 2001, 112:198-204.
26. Fallgatter A.J., Brandeis D., Strik W.K. A robust assessment of the NoGo-anteriorisation of P300 microstates in a cued continuous performance test. Brain Topogr. 1997, 9:295-302.
27. Fallgatter A.J., Ehlis A.C., Rosler M., Strik W.K., Blocher D., Herrmann M.J. Diminished prefrontal brain function in adults with psychopathology in childhood related to attention deficit hyperactivity disorder. Psychiatry Res. 2005, 138:157-169.
28. Fallgatter A.J., Herrmann M.J., Hohoff C., Ehlis A.C., Jarczok T.A., Freitag C.M., Deckert J. DTNBP1 (dysbindin) gene variants modulate prefrontal brain function in healthy individuals. Neuropsychopharmacology 2006, 31:2002-2010.
29. Fallgatter A.J., Jatzke S., Bartsch A.J., Hamelbeck B., Lesch K.P. Serotonin transporter promoter polymorphism influences topography of inhibitory motor control. Int. J. Neuropsychopharmacol. 1999, 2:115-120.
30. Fallgatter A.J., Strik W.K. The NoGo-anteriorization as a neurophysiological standard-index for cognitive response control. Int. J. Psychophysiol. 1999, 32:233-238.
31. Faraone S.V., Doyle A.E. Genetic influences on attention deficit hyperactivity disorder. Curr. Psychiatry Rep. 2000, 2:143-146.
32. Faraone S.V., Perlis R.H., Doyle A.E., Smoller J.W., Goralnick J.J., Holmgren M.A., Sklar P. Molecular genetics of attention-deficit/hyperactivity disorder. Biol. Psychiatry 2005, 57:1313-1323.
33. Franke B., Arias Vasquez A., Johansson S., Hoogman M., Romanos J., Boreatti-Huemmer A., et al. Meta-analysis of the SLC6A3/DAT1 VNTR haplotype in adult ADHD suggests differential involvement of the gene in adult and childhood ADHD. Neuropsychopharmacology 2010, 35:656-664.
34. Franke, B., Faraone, S.V., Asherson, P., Buitelaar, J., Bau, C.H., Ramos-Quiroga, J.A., Mick, E., Grevet, E.H., Johansson, S., Haavik, J., Lesch, K.P., Cormand, B., Reif, A., 2012. The genetics of attention deficit/hyperactivity disorder in adults, a review. Mol. Psychiatry 17/10, 1476-5578.
35. Fuchs M., Kastner J., Wagner M., Hawes S., Ebersole J.S. A standardized boundary element method volume conductor model. Clin. Neurophysiol. 2002, 113:702-712.
36. Gizer I.R., Ficks C., Waldman I.D. Candidate gene studies of ADHD: a meta-analytic review. Hum. Genet. 2009, 126:51-90.
37. Gratton G., Coles M.G.H. Generalization and evaluation of eye-movement correction procedures. J. Psychophysiol. 1989, 3:1-50.
38. Hanisch C., Radach R., Holtkamp K., Herpertz-Dahlmann B., Konrad K. Oculomotor inhibition in children with and without attention-deficit hyperactivity disorder (ADHD). J. Neural Transm. 2006, 113:671-684.
39. Hariri A.R., Mattay V.S., Tessitore A., Kolachana B., Fera F., Goldman D., Egan M.F., Weinberger D.R. Serotonin transporter genetic variation and the response of the human amygdala. Science 2002, 297:400-403.
40. Hariri A.R., Weinberger D.R. Imaging genomics. Br. Med. Bull. 2003, 65:259-270.
41. Heinzel, S., Dresler, T., Baehne, C.G., Heine, M., Boreatti-Hümmer, A., Jacob, C.P., Renner, T.J., Reif, A., Lesch, K.P., Fallgatter, A.J., Ehlis, A.C.. COMT x DRD4 epistasis impacts prefrontal cortex function underlying response control. Cerebral Cortex, , in press. http://10.1093/cercor/bhs132.
42. Herold C., Becker T. Genetic association analysis with FAMHAP: a major program update. Bioinformatics 2009, 1:134-136.
43. Ichtchenko K., Khvotchev M., Kiyatkin N., Simpson L., Sugita S., Sudhof T.C. Alpha-latrotoxin action probed with recombinant toxin: receptors recruit alpha-latrotoxin but do not transduce an exocytotic signal. EMBO J. 1998, 17:6188-6199.
44. Jacob C.P., Romanos J., Dempfle A., Heine M., Windemuth-Kieselbach C., Kruse A., Reif A., Walitza S., Romanos M., Strobel A., Brocke B., Schafer H., Schmidtke A., Boning J., Lesch K.P. Co-morbidity of adult attention-deficit/hyperactivity disorder with focus on personality traits and related disorders in a tertiary referral center. Eur. Arch. Psychiatry Clin. Neurosci. 2007, 257:309-317.
45. Jasper H. Report of committee on methods of clinical exam in EEG. Electroencephalogr Clin. Neurophysiol. 1958, 10:370-375.
46. Jurcak V., Tsuzuki D., Dan I. 10/20, 10/10, and 10/5 systems revisited: their validity as relative head-surface-based positioning systems. Neuroimage 2007, 34:1600-1611.
47. Kendler K.S., Neale M.C. Endophenotype: a conceptual analysis. Mol. Psychiatry 2010, 15:789-797.
48. Kessler R.C., Adler L., Barkley R., Biederman J., Conners C.K., Demler O., Faraone S.V., Greenhill L.L., Howes M.J., Secnik K., Spencer T., Ustun T.B., Walters E.E., Zaslavsky A.M. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am. J. Psychiatry 2006, 163:716-723.
49. Krain A.L., Castellanos F.X. Brain development and ADHD. Clin. Psychol. Rev. 2006, 26:433-444.
50. Lehmann D. Principles of spatial analysis. Handbook of Electroencephalography and Clinical NeurophysiologyMethods of Analysis of Brain Electrical and Magnetic Signals 1987, vol. 1:309-354. Elsevier, Amsterdam.
51. Levy F., Hay D.A., McStephen M., Wood C., Waldman I. Attention-deficit hyperactivity disorder: a category or a continuum? Genetic analysis of a large-scale twin study. J. Am. Acad. Child Psychiatry 1997, 36:737-744.
52. Lionel A.C., Crosbie J., Barbosa N., Goodale T., Thiruvahindrapuram B., Rickaby J., Gazzellone M., Carson A.R., Howe J.L., Wang Z., et al. Rare copy number variation discovery and cross-disorder comparisons identify risk genes for ADHD. Sci. Translational Med. 2011, 3:95ra75.
53. Losier B.J., McGrath P.J., Klein R.M. Error patterns on the continuous performance test in non-medicated and medicated samples of children with and without ADHD: a meta-analytic review. J. Child Psychol. Psychiatry 1996, 37:971-987.
54. Mannuzza S., Klein R.G., Bessler A., Malloy P., LaPadula M. Adult outcome of hyperactive boys. Educational achievement, occupational rank, and psychiatric status. Arch. Gen. Psychiatry 1993, 50:565-576.
55. Martel M., Nikolas M., Nigg J.T. Executive function in adolescents with ADHD. J. Am. Acad. Child Psychiatry 2007, 46:1437-1444.
56. Martin N., Scourfield J., McGuffin P. Observer effects and heritability of childhood attention-deficit hyperactivity disorder symptoms. Br. J. Psychiatry 2002, 180:260-265.
57. Martinez A.F., Muenke M., Arcos-Burgos M. From the black widow spider to human behavior: Latrophilins, a relatively unknown class of G protein-coupled receptors, are implicated in psychiatric disorders. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 2011, 156:1-10.
58. Marzinzik F., Wahl M., Krüger D., Gentschow L., Colla M., Klostermann F. Abnormal distracter processing in adults with attention-deficit-hyperactivity disorder. PLoS One 2012, 7(3):e33691.
59. Matza L.S., Paramore C., Prasad M. A review of the economic burden of ADHD. Cost effect. Res. Allocation 2005, 3:5.
60. Nigg J.T. The ADHD response-inhibition deficit as measured by the stop task: replication with DSM-IV combined type, extension, and qualification. J. Abnorm. Child. Psychiatry 1999, 27:393-402.
61. O'Sullivan M.L., de Wit J., Savas J.N., Comoletti D., Otto-Hitt S., Yates J.R., Ghosh A. FLRT proteins are endogenous latrophilin ligands and regulate excitatory synapse development. Neuron 2012, 73:903-910.
62. Pascual-Marqui R.D. Standardized low-resolution brain electromagnetic tomography (sLORETA): technical details. Methods Find Exp. Clin. Pharmacol. 2002, 24(Suppl. D):5-12.
63. Polanczyk G., de Lima M.S., Horta B.L., Biederman J., Rohde L.A. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am. J. Psychiatry 2007, 164:942-948.
64. Retz-Junginger P., Retz W., Blocher D., Weijers H.G., Trott G.E., Wender P.H., Rossler M. Wender Utah rating scale. The short-version for the assessment of the attention-deficit hyperactivity disorder in adults. Nervenarzt 2002, 73:830-838.
65. Rosvold H.E., Mirsky A., Sarason I., Bransome E.D., Beck L.H. A continuous performance test of brain damage. J. Consult. Psychol. 1956, 20:343-350.
66. Rubia K., Overmeyer S., Taylor E., Brammer M., Williams S.C., Simmons A., Bullmore E.T. Hypofrontality in attention deficit hyperactivity disorder during higher-order motor control: a study with functional MRI. Am. J. Psychiatry 1999, 156:891-896.
67. Rubia K., Smith A.B., Brammer M.J., Toone B., Taylor E. Abnormal brain activation during inhibition and error detection in medication-naive adolescents with ADHD. Am. J. Psychiatry 2005, 162:1067-1075.
68. Saß H., Wittchen H., Zaudig M. Diagnostische Kriterien (DSM-IV-TR) 2003, Hogrefe, Göttingen.
69. Schweitzer J.B., Faber T.L., Grafton S.T., Tune L.E., Hoffman J.M., Kilts C.D. Alterations in the functional anatomy of working memory in adult attention deficit hyperactivity disorder. Am. J. Psychiatry 2000, 157:278-280.
70. Skounti M., Philalithis A., Galanakis E. Variations in prevalence of attention deficit hyperactivity disorder worldwide. Eur. J. Pediatr. 2007, 166:117-123.
71. Slaats-Willemse D.I.E. Cognitive Endophenotypes of ADHD 2003, Ponsen & Looijen BV, Wageningen.
72. Sonuga-Barke E.J. The dual pathway model of AD/HD: an elaboration of neuro-developmental characteristics. Neurosci. Biobehav. Rev. 2003, 27:593-604.
73. Sonuga-Barke E., Bitsakou P., Thompson M. Beyond the dual pathway model: evidence for the dissociation of timing, inhibitory, and delay-related impairments in attention-deficit/hyperactivity disorder. J. Am. Acad. Child Adolescent Psychiatry 2010, 49:345-355.
74. Spencer R.C., Klein R.M., Berridge C.W. Psychostimulants act within the prefrontal cortex to improve cognitive function. Biol. Psychiatry 2012, 72:221-227.
75. Spronk M., Jonkman L.M., Kemner C. Response inhibition and attention processing in 5- to 7-year-old children with and without symptoms of ADHD: An ERP study. Clin. Neurophysiol. 2008, 119:2738-2752.
76. Sugita S., Ichtchenko K., Khvotchev M., Sudhof T.C. Alpha-Latrotoxin receptor CIRL/latrophilin 1 (CL1) defines an unusual family of ubiquitous G-protein-linked receptors. G-protein coupling not required for triggering exocytosis. J. Biol. Chem. 1998, 273:32715-32724.
77. Uebel H., Albrecht B., Asherson P., Börger N.A., Butler L., Chen W., Christiansen H., Heise A., Kuntsi J., Schäfer U., Andreou P., Manor I., Marco R., Miranda A., Mulligan A., Oades R.D., van der Meere J., Faraone S.V., Rothenberger A., Banaschewski T. Performance variability, impulsivity errors and the impact of incentives as gender-independent endophenotypes for ADHD. J. Child Psychol. Psychiatry 2010, 37:201-218.
78. Vaidya C.J., Austin G., Kirkorian G., Ridlehuber H.W., Desmond J.E., Glover G.H., Gabrieli J.D. Selective effects of methylphenidate in attention deficit hyperactivity disorder: a functional magnetic resonance study. Proc. Natl. Acad. Sci. USA 1998, 95:14494-14499.
79. Zobel A., Maier W. Endophänotypen-ein neues Konzept zur biologischen Charakterisierung psychischer Störungen (Endophenotype-a new concept for biological characterization of psychiatric disorders). Nervenarzt 2004, 75:205-214.